How AbraSilver Resource Corp. is using Condoryacu to widen the strategic upside at Diablillos before feasibility results (TSX: ABRA)
What this small Australia acquisition reveals about Arthur J. Gallagher & Co.’s bigger strategy (NYSE: AJG)
What the Blacklane acquisition means for Uber Technologies, Inc.’s luxury and corporate travel ambitions (NYSE: UBER)
Why Flex Ltd.’s $1.1bn EP2 acquisition signals rising confidence in U.S. grid modernization spending (NASDAQ: FLEX)
Read More Pharma Industry News Quoin Pharmaceuticals raises up to $104.5M in private placement to fuel its rare disease pipeline Find out how Quoin Pharmaceuticals secured up to $104.5 million in a milestone-linked private placement to advance its rare disease therapy QRX003 and strengthen investor confidence. bySoujanya RaviOctober 10, 2025